Top Markets
#1 Status Status +20.04%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#3 Ontology Gas Ontology Gas +12.46%
#4 GoPlus Security GoPlus Security +12.16%
#5 DMT-NAT DMT-NAT +9.70%
#6 Fake World Assets Fake World Assets +8.34%
#7 Provenance Blockchain Provenance Blockchain +6.75%
#8 Bedrock Bedrock +6.48%
#9 Janction Janction +6.24%
#10 Ontology Ontology +5.54%
Coin of the day
Status Status
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Rang in aandelen #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Aandeelprijs
$0.223
Laatst gesynchroniseerd: 2026-08-14
Marktkapitalisatie
$6.32M
Verandering (1 dag)
1.64%
Verandering (1 jaar)
-
Land
US
Handel Curanex Pharmaceuticals Inc Common Stock (CURX)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Curanex Pharmaceuticals Inc Common Stock (CURX)
Het dividendrendement (TTM) van Curanex Pharmaceuticals Inc Common Stock (aandelsymbool: CURX) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Curanex Pharmaceuticals Inc Common Stock (CURX) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE